Research Project

Project Title:	A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Subjects With Immunoglobulin A Nephropathy.
Project Type:	Clinical Trial, Enrolment not yet started
Disease group(s):	Immune glomerulopathies
Project Summary:	Phase 3, multicentre, randomised, double-blind, placebo-controlled trial to evaluate the efficacy and safety of sibeprenlimab administered subcutaneously in subjects with immunoglobulin A nephropathy.
Lead principal investigator(s):	Gaetano La Manna, Bologna
Co-investigator(s):	Olga Baraldi, Bologna
Project Period:	03/2023 - 03/2050
Sponsors:	Industry
Project web page:	https://www.clinicaltrials.gov/study/NCT05248646
ClinicalTrials.gov:	NCT05248646